NCT05161494Completed
Gait in Rare Diseases
Identification of Gait Disorders in Children, Adolescents and Young Adults With Rare Genetic Diseases
Source: ClinicalTrials.gov · Last updated 7 May 2026
Brief summary (registry, in English)
The aim of this pilot study is to explore whether the knowledge and experience gained during the T-GaiD project (Treatment of Gait Disorders in Dravet Syndrome - NCT03857451) can be transferred to other populations with similar problems, i.e. motor and gait problems as a result of a genetic disorder characterized by epilepsy and developmental delay. In this pilot study, 40 people with Tuberous Sclerosis Complex and 30 people with STXBP1 will be recruited via the Antwerp University Hospital and invited for a gait analysis in the M²OCEAN movement lab. The aim of the pilot study is to evaluate the feasibility of the 3D gait analysis protocol and to determine the sensitivity of the primary (summative measure of the severity of gait abnormalities) and the secondary (spatio-temporal and kinematic gait parameters) outcome measures.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 41 (actual)
- First submitted
- 30 Nov 2021
- Start date
- 25 Jan 2022
- Primary completion date
- 1 Jul 2025
- Lead sponsor
- Universiteit Antwerpen
- Diseases
- Epilepsy
- NCT number
- NCT05161494
What you commit to
- Study type: Observational
- Participants enrolled: 41
- From 25 Jan 2022 to the primary completion date, 1 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- severe epileptic seizure (status epilepticus or tonic-clonic insult over 3 min) within the 24 hours before the assessment
Other
- insufficient cooperation to perform 3D gait analysis
Who the study is looking for
- diagnosed with tuberous sclerosis complex according to the criteria of Northrup et al. (2012)
- aged 6 years or older
- being able to walk without aids for a minimum distance of 6 meters
Age in the registry: 6 years to 25 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Antwerp Coordinator of this site? Confirm its status | Antwerp | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.